Last update 24 Dec 2024

Bulevirtide Acetate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Bulevirtide, MyrB, Myrcludex-B
+ [7]
Target
Mechanism
NTCP modulators(Sodium/bile acid cotransporter modulators)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
EU (31 Jul 2020),
RegulationOrphan Drug (EU), PRIME (EU), Orphan Drug (AU), Priority Review (AU), Conditional marketing approval (EU), Orphan Drug (GB), Breakthrough Therapy (US), Orphan Drug (US)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hepatitis D, Chronic
EU
31 Jul 2020
Hepatitis D, Chronic
IS
31 Jul 2020
Hepatitis D, Chronic
LI
31 Jul 2020
Hepatitis D, Chronic
NO
31 Jul 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis DPhase 3--
Hepatitis DPhase 3--
Hepatitis B, ChronicPhase 2
RU
01 Apr 2016
Hepatitis C, ChronicPhase 2-13 Feb 2014
Hepatitis BPhase 2--
Liver Cirrhosis, BiliaryPreclinical
DE
04 Apr 2018
DyslipidemiasPreclinical
DE
24 Mar 2018
Nonalcoholic SteatohepatitisPreclinical
DE
20 Mar 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
269
pbtmdgzywi(ktqpcmzdfs) = Neither hepatic decompensation nor death occurred cmwdgblyhl (byebsgkofd )
Positive
08 Dec 2024
Not Applicable
-
Bulevirtide (BLV) treatment
igzffefrjl(ayyyfeiuxk) = During follow-up, three (3.6%) patients – all without BLV treatment - were diagnosed with hepatocellular carcinoma and overall, five (6.0%) patients died, of which four deaths were liver-related eyaulxaqfu (lxhvxuvvfo )
-
13 Oct 2024
Not Applicable
-
devtlezdyw(oyrlrfwkfq) = the 10mg group showed a significantly higher incidence compared to the control group yxtwtwhzdc (hbuvbwqnts )
-
20 May 2024
Not Applicable
420
nayrzxucer(vvmswshqbz) = no significant differences between both doses tajsmzodoh (pdeyybjlfr )
Negative
20 May 2024
Not Applicable
-
krfwiskffj(vlttkaffhs) = 10mg group showed a significantly higher incidence compared to the control group lzgdztwkab (gonagfzkeq )
-
20 May 2024
Control
Not Applicable
420
ldfdfkncun(rrwaamznrw) = the 10mg group showed a significantly higher incidence compared to the control group aijvhshlal (qybtxtzryh )
Negative
20 May 2024
Phase 2
Hepatitis D, Chronic
HBsAg-positive hepatocytes
126
ludniamurn(kcxgwbridt) = ybwsvsyknf whnhhmdqyd (bvaofbryod )
Positive
08 Feb 2024
ludniamurn(kcxgwbridt) = capumotouo whnhhmdqyd (bvaofbryod )
Not Applicable
46
knrsimdlok(ixgchpeaqv) = qfjlbfdygu ejlgjdvvam (ftrvrfvfwx )
-
10 Nov 2023
Not Applicable
44
dmrmmrgwus(chfnmacyge) = khnmouzucj qpfdfrkpmy (chfixbqsms, 0.70 - 6.60)
-
10 Nov 2023
dmrmmrgwus(chfnmacyge) = rfzrndacjp qpfdfrkpmy (chfixbqsms, 0.45 - 6.80)
Not Applicable
128
BLV 2 mg
vorbscdjdk(akqjhewbzp) = zjtaoelfbm nfgghhyhsk (sesooxopig )
-
10 Nov 2023
BLV 10 mg
vorbscdjdk(akqjhewbzp) = kutjfqltlc nfgghhyhsk (sesooxopig )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free